Diuretic Strategies in Acute Decompensated Heart Failure

被引:13
作者
Hardin E.A. [1 ]
Grodin J.L. [1 ]
机构
[1] Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, 75390-9047, TX
关键词
Acute decompensated heart failure; Decongestive; Diuretic; Heart failure;
D O I
10.1007/s11897-017-0319-y
中图分类号
学科分类号
摘要
Purpose of Review: The burden of heart failure in the United States is growing rapidly to epic proportions with serious clinical implications for patients and economic strain for healthcare systems. One of the most common reasons for hospitalization in acute decompensated heart failure (ADHF) is excess volume accumulation which leads to untoward symptoms including dyspnea,orthopnea, and edema. Recent Findings: Over the past several decades, there has been great interest in exploring various decongestive strategies in order to achieve symptomatic improvement and favorable clinical outcomes. These include different modalities of loop diuretic administration, the adjunctive use of non-loop diuretics, and other diuretic sparing strategies. Summary: Herein, we provide an appraisal of these decongestive strategies and discuss novel concepts predicting clinical outcomes based on diuretic response and decongestive adequacy while discussing commonly encountered problems such as worsening renal function in ADHF. © 2017, Springer Science+Business Media New York.
引用
收藏
页码:127 / 133
页数:6
相关论文
共 53 条
[1]  
Buggey J., Mentz R.J., Pitt B., Et al., A reappraisal of loop diuretic choice in heart failure patients, Am Heart J, 169, pp. 323-333, (2015)
[2]  
Go A.S., Mozaffarian D., Roger V.L., Et al., Heart disease and stroke statistics—2014 update: a report from the American Heart Association, Circulation, 129, pp. e28-e292, (2014)
[3]  
Lloyd-Jones D., Adams R., Carnethon M., Et al., Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 119, pp. 480-486, (2009)
[4]  
Adams K.F., Fonarow G.C., Emerman C.L., Et al., Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE), Am Heart J, 149, pp. 209-216, (2005)
[5]  
Ambrosy A.P., Pang P.S., Khan S., Et al., Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial, Eur Heart J, 34, pp. 835-843, (2013)
[6]  
Yancy C.W., Jessup M., Bozkurt B., Et al., 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 62, pp. e147-e239, (2013)
[7]  
Ponikowski P., Voors A.A., Anker S.D., Et al., 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur Heart J, 37, pp. 2129-2200, (2016)
[8]  
Lindenfeld J., Albert N.M., Boehmer J.P., Et al., HFSA 2010 comprehensive heart failure practice guideline, J Card Fail, 16, pp. e1-e194, (2010)
[9]  
Murray M.D., Haag K.M., Black P.K., Hall S.D., Brater D.C., Variable furosemide absorption and poor predictability of response in elderly patients, Pharmacotherapy, 17, pp. 98-106, (1997)
[10]  
Wargo K.A., Banta W.M., A comprehensive review of the loop diuretics: should furosemide be first line?, Ann Pharmacother, 43, pp. 1836-1847, (2009)